UPDATE 1-U.S. panel backs approval of Sanofi combination diabetes drug
May 25, 2016 at 16:59 PM EDT
May 25 (Reuters) - One day after recommending approval of a new diabetes drug made by Novo Nordisk A/S, a U.S. advisory panel on Wednesday recommended approval of a similar product made by Sanofi SA.
